Switching from a PharmacyLive portal without disrupting refill day

Before moving any volume, confirm the platform layer change does not disrupt the pharmacy layer underneath. First, check formulary coverage: list your highest-volume SKUs — semaglutide, tirzepatide, your hormone and peptide lines — and confirm the LegitScript-certified 503A partners assigned to your Fizy Health clinic can fill them. PharmacyLive is prescriber portal software on the pharmacy side, not a compounder itself — the actual medications come from 503A pharmacies, so coverage across every partner you route to is the first thing to verify.

Second, understand what you are leaving behind. Your compounder's PharmacyLive portal is one pharmacy's branded deployment — batch ordering, catalog depth, and pricing are set by that pharmacy buyer. If you still need that specific compounder for certain SKUs, you may run Fizy Health for multi-partner batch checkout and keep the PharmacyLive portal for lines only that pharmacy fulfills. Third, decide what data you carry over: patient demographics, your common SIGs, and your repeat-order SKUs. None of this requires an EMR migration — prescriber portals live alongside your chart system, not in place of it.

The lowest-risk path is to run both workflows side by side for a short window rather than cutting over cold. Create a free Fizy Health account at app.fizy.health, complete clinic and prescriber verification (NPI and DEA are validated at onboarding), and add patients from your existing list or create them inline while building your first cart. Then open catalog and cart for your top GLP-1 and hormone lines and compare pass-through per-vial cost against the pricing your compounder configured inside their PharmacyLive portal.

Run your first validated batch cart for a single refill day: add today's patient lines, let cart validation catch SIG and licensure issues before checkout, and submit one payment. Tracking and in-app support start per line from day one. Keep the PharmacyLive portal active until you have confirmed pricing, coverage, and workflow over one or two refill cycles — then shift the rest of your volume. If pass-through pricing does not beat your current pharmacy-configured rates on your top SKUs, that is a legitimate reason to stay. Switch on the numbers, not the pitch.